Literature DB >> 7922268

In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy.

A C Allen1, L Layward, S J Harper, J Feehally.   

Abstract

IgA nephropathy (IgAN) is characterized by mesangial IgA deposition, and up-regulation of the IgA system is frequently described. This study investigated in vitro immunoglobulin isotype production by peripheral blood mononuclear cells from patients with IgAN and controls, without mitogenic stimulation and under the influence of cell cycle inhibitors and cyclosporin A (CyA). In controls, only IgM production was suppressed by cell cycle inhibitors, and no isotype was affected by CyA. This suppressible IgM production may represent antigen-independent 'natural antibody'. In IgAN, IgM, IgA and IgG were all suppressed by cell cycle inhibitors, and CyA suppressed IgA production. This state of altered immune activation in IgAN demonstrates T-cell-independent IgA production, suggesting that it is IgA 'natural antibody'. In conclusion, we suggest that mesangial IgA deposition may not be antigen dependent but due to some non-immune characteristic of the IgA molecule.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922268

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  3 in total

1.  Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathy.

Authors:  Jae Il Shin; Beom Jin Lim; Pyung Kil Kim; Jae Seung Lee; Hyeon Joo Jeong; Ji Hong Kim
Journal:  J Korean Med Sci       Date:  2010-04-22       Impact factor: 2.153

2.  Could intravenous cyclosporin A be an effective therapeutic strategy in pulmonary hemorrhage associated with Henoch-Schönlein purpura? Comment on: Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child [Clin Rheumatol 27(6):803-805].

Authors:  Jae Il Shin; Jae Seung Lee
Journal:  Clin Rheumatol       Date:  2008-08-21       Impact factor: 2.980

3.  Alum Directly Modulates Murine B Lymphocytes to Produce IgG1 Isotype.

Authors:  Bo-Ra Jin; Sun-Jin Kim; Jeong-Min Lee; Seong-Ho Kang; Hye-Ju Han; Young-Saeng Jang; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Immune Netw       Date:  2013-02-28       Impact factor: 6.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.